Clinical Trial Update: Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Ang-(1-7) to enhance cognitive function in patients undergoing coronary artery bypass grafting; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: University of Arizona | Conditions: Coronary Artery Bypass Surgery, Cognitive Impairment | Phase 2 | Status: TERMINATED